Hansen T, Unger R E, Gaumann A, Hundorf I, Maurer J, Kirkpatrick C J, Kriegsmann J
Institute of Pathology, Johannes Gutenberg-University, Mainz, Germany.
Mod Pathol. 2001 Dec;14(12):1226-31. doi: 10.1038/modpathol.3880465.
Cholesteatoma is a nonneoplastic lesion of the middle ear space or mastoid that is histologically characterized by a progressive bone erosion of the ossicles and surrounding bone. Several matrix-degrading enzymes have been implicated as mediators of this bone erosion. Because the novel cysteine proteinase cathepsin K has been shown to play a central role in bone resorption, we examined the expression of this enzyme in tissue specimens of cholesteatoma. Tissue specimens of 9 patients with cholesteatoma were obtained during middle-ear surgery. Expression of cathepsin K mRNA was determined by RT-PCR using specific primers. Immunohistochemical analysis of cathepsin K protein expression in tissue sections was performed by using the streptavidin-alkaline phosphatase technique. Expression of both cathepsin K mRNA and protein was detected in areas affected by cholesteatoma, whereas specimens of nonaffected ear cartilage and surrounding tissue were not positive. In addition, cathepsin K was detected in numerous multinucleated giant cells, particularly osteoclasts at the site of bone degradation. In contrast, keratinized squamous epithelium was negative for cathepsin K. These data demonstrate that the matrix-degrading cysteine proteinase cathepsin K may be involved in bone erosion in cholesteatoma. Strong expression of this collagenolytic enzyme in osteoclasts suggests that these cells are mainly involved in cathepsin K-mediated bone destruction.
胆脂瘤是中耳腔或乳突的一种非肿瘤性病变,其组织学特征为听小骨和周围骨质的进行性骨质侵蚀。几种基质降解酶被认为是这种骨质侵蚀的介质。由于新型半胱氨酸蛋白酶组织蛋白酶K已被证明在骨吸收中起核心作用,我们检测了该酶在胆脂瘤组织标本中的表达。在中耳手术期间获取了9例胆脂瘤患者的组织标本。使用特异性引物通过逆转录聚合酶链反应(RT-PCR)测定组织蛋白酶K mRNA的表达。采用链霉亲和素 - 碱性磷酸酶技术对组织切片中组织蛋白酶K蛋白表达进行免疫组织化学分析。在胆脂瘤累及区域检测到组织蛋白酶K mRNA和蛋白的表达,而未受累耳软骨及周围组织标本呈阴性。此外,在许多多核巨细胞中检测到组织蛋白酶K,特别是在骨质破坏部位的破骨细胞中。相比之下,角化鳞状上皮组织蛋白酶K呈阴性。这些数据表明,基质降解半胱氨酸蛋白酶组织蛋白酶K可能参与胆脂瘤的骨质侵蚀。这种胶原分解酶在破骨细胞中的强表达表明这些细胞主要参与组织蛋白酶K介导的骨质破坏。